The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily ...

"Nothing would do more to improve the health, lifespan, and quality of life for Americans than making [GLP-1 drugs] super low ...

In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...

The prevalence of substance use disorders, such as opioid and alcohol use disorders, has created a significant public health ...

A noticeably slimmed-down Elon Musk joked about his weight loss after he was photographed dressed up as Old Saint Nick.

Elon Musk has revealed he has upgraded from Ozempic to Mounjaro, nicknamed the “King Kong” of weight-loss drugs, in a photo ...

Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...

Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...

Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...

Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high costs—often exceeding $1,000 per month—put them out of reach for many Americans whose ...

MassHealth is transitioning coverage for anti-obesity drugs, designating Zepbound as the preferred option starting in January 2025, with Wegovy and Saxenda being discontinued for most adult members.